Open AccessInterim analysis results from the RESTORE-CLI, a randomized, double-blind multicenter phase II trial comparing expanded autologous bone marrow-derived tissue repair cells and placebo in patients with critical limb ischemia
Author(s) -
Richard J. Powell,
Anthony J. Comerota,
Scott A. Berceli,
Raul J. Guzman,
Timothy D. Henry,
Edith Tzeng,
Omaida C. Velázquez,
William A. Marston,
Ronnda L. Bartel,
Amy Longcore,
Theresa Stern,
Sharon M. Watling
Publication year - 2011
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/1622-x682
Subject(s) - critical limb ischemia , medicine , placebo , interim analysis , double blind , interim , bone marrow , ischemia , surgery , randomized controlled trial , urology , pathology , vascular disease , archaeology , history , arterial disease , alternative medicine